Eastman Chemical Company - Q1 2006 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Eastman Chemical Company for the period ended March 31, 2006. The Company operates in five reportable segments: Coatings, Adhesives, Specialty Polymers and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Polymers; and Specialty Plastics (SP). During the quarter, the Company realigned its organizational structure to eliminate interdivisional sales revenue and operating earnings, resulting in restated 2005 segment figures for comparability.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2006 | Q1 2005 |
|---|---|---|
| Sales | $1,803 | $1,762 |
| Gross Profit | $331 | $399 |
| Gross Margin | 18.4% | 22.7% |
| Operating Earnings | $184 | $244 |
| Net Earnings | $105 | $162 |
| Diluted EPS | $1.27 | $2.00 |
| Operating Cash Flow | $37 | $103 |
| Cash and Equivalents (End of Period) | $485 | $393 |
| Total Debt (Long-term + Current) | $1,591 | $1,625 |
Material Changes vs. Prior Period
- Revenue: Sales increased 2% ($41 million) driven by higher selling prices (5% effect) offset by unfavorable product mix (-2%) and exchange rates (-2%).
- Profitability: Operating earnings declined 25% ($60 million) and Net Earnings declined 35% ($57 million). The decline was primarily due to reduced gross margins in the Polymers segment and operational disruptions at the Longview, Texas facility costing approximately $19 million.
- Cash Flow: Operating cash flow decreased $66 million, attributed to lower net earnings, the payout of 2005 incentive compensation, and increased pension funding.
- Segment Performance:
- Polymers: Operating earnings dropped 80% ($67 million) due to lower PET selling prices and volumes.
- Fibers: Operating earnings increased 38% ($18 million) due to strong demand for acetate tow.
- CASPI: Operating earnings decreased 18% ($12 million) due to lower volumes and currency effects.
Guidance, Outlook, and Risks
Outlook for 2006:
- Capital expenditures are expected to reach up to $450 million, driven by the new PET facility in South Carolina (IntegRex technology) and copolyester expansions.
- Net interest expense is expected to decrease due to lower average borrowings.
- Effective tax rate is projected at approximately 35%.
- R&D costs are expected to be approximately 3% of revenue.
- Q2 2006 earnings per share are expected to be similar to Q1 2006, excluding asset impairments and restructuring charges.
Risks and Contingencies:
- Raw Materials: Continued volatility in raw material and energy costs poses a risk to gross margins.
- Legal: Ongoing asbestos litigation (approx. 1,500 pending claims) and sorbates litigation. Management does not believe these will have a material adverse effect overall.
- Environmental: Reserves for environmental contingencies were $53 million at March 31, 2006.
- Accounting Changes: Adoption of SFAS No. 123(R) for share-based compensation resulted in the recognition of stock option expense in earnings starting Q1 2006.
Investor Verification Checklist
- Verify the impact of the $19 million operational disruption at the Longview, Texas facility on future Q2 and Q3 production schedules.
- Monitor the progress and cost overruns of the new IntegRex PET facility in South Carolina, a key driver of the $450 million capital expenditure plan.
- Review the status of the asbestos litigation and the adequacy of the insurance coverage agreement finalized with the predecessor insurer.
- Assess the sustainability of the Polymers segment's margin recovery given the global capacity utilization rates for PET.
- Confirm the Company's ability to maintain investment-grade credit ratings given the increased capital spending and pension funding requirements ($75 million expected for 2006).